VI Ventures

VI Ventures is a boutique venture capital firm focused on investing in the Medtech and Technology, Media, and Telecommunications sectors. With a mission to support entrepreneurs in their efforts to improve the world, the firm targets investments in companies located in the United States, China, and Israel. VI Ventures operates offices in Hong Kong, Shenzhen, and Shanghai, enabling it to engage with innovative businesses in key global markets.

Vic Lee

Co-Founder and Managing Partner

Tianhong Xu Ph.D

Partner

2 past transactions

HiFiBiO

Series C in 2019

HiFiBiO is a biotherapeutics company focused on harnessing the human immune system to address diseases, particularly cancer and autoimmune disorders. Founded in 2013 and based in Paris, the company specializes in proprietary single-cell technologies that facilitate drug and biomarker discovery and development. HiFiBiO's platform combines extensive biological knowledge with advanced single-cell profiling techniques, allowing for the rapid identification and advancement of antibody drugs. Through partnerships with both industry and academic institutions, HiFiBiO aims to promote open innovation and enhance patient outcomes by unlocking the therapeutic potential of the immune system.

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.